Immatics N.V. ( IMTX) - Key Metrics
IMTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.07 | -$0.46 | -$0.45 | -$0.45 |
| 2026Q1 | $0.06 | -$0.43 | -$0.32 | -$0.32 |
| 2025Q4 | $0.16 | -$0.28 | -$0.46 | -$0.46 |
| 2025Q3 | $0.04 | -$0.42 | -$0.37 | -$0.38 |
| 2025Q2 | $0.04 | -$0.58 | -$0.32 | -$0.33 |
IMTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.82 |
| 2026Q1 | 0% | -4.95 |
| 2025Q4 | 0% | -7.98 |
| 2025Q3 | 0% | -4.32 |
| 2025Q2 | 0% | -1.97 |
IMTX
Price: $6.73
52 week price:
Earnings Per Share: -1.98 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Germany
Volume: 207152
Market Capitalization: 1.0 billion